V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330006355 | 330003147 | 1.77 | null | Curative (C) | 2018-03-14 | 2018-03-14 | CISPLATIN + RT | N | Y | 330001213 | CISPLATIN + RT |
| 330006356 | 330003148 | 1.06 | 7.2 | Curative (C) | null | 2016-08-10 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330001226 | NOT MATCHED |
| 330006357 | 330003148 | 1.6 | 96 | Curative (C) | 2015-06-19 | 2015-12-11 | CNS LGG 2004 03 cons vinc + carbo | N | N | 330001226 | NOT MATCHED |
| 330006358 | 330003150 | 1.54 | 91.2 | Curative (C) | 2013-02-18 | 2013-02-20 | Cisplatin 100 + RT(H&N) 1 day | null | Y | 330001235 | CISPLATIN + RT |
| 330006359 | 330003151 | null | null | Neo-adjuvant (N) | 2017-12-03 | 2017-12-05 | EW EuroEwing 2012 Arm B VC | N | null | 330001235 | NOT MATCHED |
| 330006360 | 330003152 | 1.66 | null | Neo-adjuvant (N) | 2015-10-06 | 2015-10-11 | CISPLATIN + RT | null | null | 330001243 | CISPLATIN + RT |
| 330006361 | 330011563 | null | null | Neo-adjuvant (N) | 2014-11-08 | 2015-01-05 | NB HRNBL-1 COJEC Ind COURSE A | N | null | 330001265 | NOT MATCHED |
| 330006362 | 330003153 | 0.76 | 56.7 | Neo-adjuvant (N) | null | 2013-05-03 | NB HRNBL-1 COJEC Ind COURSE B | null | N | 330001267 | NOT MATCHED |
| 330006363 | 330003154 | 1.76 | null | Curative (C) | 2015-05-12 | 2015-05-13 | Cisplatin 100 + RT(H&N) 1 day | N | null | 330001279 | CISPLATIN + RT |
| 330006364 | 330007683 | 1.75 | null | Curative (C) | 2014-06-19 | 2014-06-19 | Cisplatin 100 + RT(H&N) 1 day | N | null | 330001301 | CISPLATIN + RT |
| 330006365 | 330003155 | null | 14 | Neo-adjuvant (N) | 2014-11-20 | 2014-12-05 | ALL Ph+ve Cons HR3 PAsp | 01 | N | 330001306 | NOT MATCHED |
| 330006366 | 330003156 | null | 15.1 | Curative (C) | 2016-05-04 | 2016-05-11 | null | N | N | 330001306 | NOT MATCHED |
| 330006367 | 330003157 | 0 | 38.3 | Curative (C) | 2015-02-12 | 2015-02-15 | AML Interim Guidelines | N | N | 330001311 | NOT MATCHED |
| 330006368 | 330003158 | 1.67 | 60.8 | Curative (C) | 2013-09-12 | 2013-09-26 | Cisplatin 100 + RT(H&N) 1 day | null | Y | 330001315 | CISPLATIN + RT |
| 330006369 | 330003159 | 1.85 | 98.4 | Palliative (P) | 2013-06-13 | 2013-07-14 | Cisplatin 100 + RT(H&N) 1 day | 02 | Y | 330001317 | CISPLATIN + RT |
| 330006370 | 330003160 | 1.32 | 29.7 | Curative (C) | 2016-11-06 | 2016-11-13 | LCHIV Cont B | Y | null | 330001321 | NOT MATCHED |
| 330006371 | 330003161 | 0 | 13.1 | Adjuvant (A) | 2015-01-14 | 2015-06-01 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | null | N | 330001321 | NOT MATCHED |
| 330006372 | 330003161 | 0 | 59 | Curative (C) | 2016-08-23 | 2016-08-23 | NB HRNBL-1 ch14.18/CHO only (trial) | Y | N | 330001321 | NOT MATCHED |
| 330006373 | 330003161 | 1.6 | 8.6 | Curative (C) | 2015-01-02 | 2015-01-21 | NB HRNBL-1 COJEC Ind COURSE A | Y | N | 330001321 | NOT MATCHED |
| 330006374 | 330012998 | 1.8 | 123.6 | Curative (C) | null | 2016-04-02 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 330001347 | CISPLATIN + RT |
| 330006375 | 330003162 | 1.68 | 83.1 | Curative (C) | 2015-09-01 | 2015-09-16 | Cisplatin 100 + RT(H&N) 1 day | 02 | Y | 330001352 | CISPLATIN + RT |
| 330006376 | 330003163 | 0 | 7.3 | Curative (C) | 2013-08-28 | 2014-01-27 | NB HRNBL-1 COJEC Ind COURSE B | N | N | 330001359 | NOT MATCHED |
| 330006377 | 330003163 | 0 | null | Curative (C) | 2016-06-01 | 2016-06-08 | NB Low/Interm risk guidelines Carbo/Etop | Y | N | 330001359 | NOT MATCHED |
| 330006378 | 330003164 | 0 | 56.9 | Curative (C) | 2016-06-14 | 2016-06-15 | null | N | N | 330001372 | NOT MATCHED |
| 330006379 | 330003165 | null | 62.1 | Curative (C) | 2014-07-10 | 2014-07-10 | Cisplatin 100 + RT(H&N) 1 day | null | Y | 330001374 | CISPLATIN + RT |
| 330006380 | 330003166 | 1.47 | 39.4 | Curative (C) | 2018-11-28 | 2018-11-29 | NB BEACON Temozolomide Irinotecan | null | N | 330001376 | NOT MATCHED |
| 330006385 | 330003170 | null | null | Not known (9) | 2016-11-26 | 2016-12-05 | Cisplatin + Radiotherapy | N | Y | 330001399 | CISPLATIN + RT |
| 330006386 | 330003170 | 1.66 | 130.6 | Curative (C) | 2016-11-08 | 2016-11-25 | Cisplatin + Radiotherapy | null | Y | 330001399 | CISPLATIN + RT |
| 330006387 | 330003170 | 1.68 | 60 | Curative (C) | 2013-12-12 | 2014-03-11 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330001399 | CISPLATIN + RT |
| 330006388 | 330003171 | 1.64 | 86 | Not known (9) | 2013-12-30 | 2014-01-31 | CISPLATIN + RT | N | Y | 330001423 | CISPLATIN + RT |
| 330006389 | 330003171 | null | 36.3 | Curative (C) | null | 2013-11-10 | NB HRNBL-1 COJEC Ind COURSE A | N | Y | 330001423 | NOT MATCHED |
| 330006390 | 330003173 | 1.64 | 57.5 | Curative (C) | 2013-06-20 | 2013-07-07 | CISPLATIN + RT | N | Y | 330001430 | CISPLATIN + RT |
| 330006391 | 330003175 | 0 | 13.3 | Curative (C) | 2017-09-24 | 2017-10-15 | NB HRNBL-1 COJEC Ind COURSE C | N | null | 330001436 | NOT MATCHED |
| 330006392 | 330011566 | 1.51 | 11.6 | Curative (C) | 2016-03-03 | 2016-04-11 | EMA High Dose | null | N | 330001437 | NOT MATCHED |
| 330006393 | 330003176 | null | 12.1 | Neo-adjuvant (N) | 2016-07-16 | 2016-07-30 | NB BEACON Temozolomide Irinotecan | 02 | null | 330001437 | NOT MATCHED |
| 330006394 | 330003178 | 1.72 | 55.4 | Curative (C) | 2014-11-30 | 2014-12-01 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330001442 | CISPLATIN + RT |
| 330006395 | 330003178 | null | 82.3 | Curative (C) | 2013-12-31 | 2014-06-10 | LCHIV Cont B | N | N | 330001442 | NOT MATCHED |
| 330006396 | 330003179 | 1.33 | 14.6 | Curative (C) | 2015-03-03 | 2015-03-03 | NB HRNBL-1 Isotretinoin | 2 | N | 330001484 | NOT MATCHED |
| 330006397 | 330003180 | 0 | 12.9 | Curative (C) | 2017-08-03 | 2017-08-27 | STS Non-Rhabdo EpSSG 2005 Ifos Dox | null | N | 330001494 | NOT MATCHED |
| 330006398 | 330007697 | 1.82 | 43 | Curative (C) | 2013-09-21 | 2013-09-21 | Cisplatin + Radiotherapy | 02 | Y | 330001518 | CISPLATIN + RT |
| 330006399 | 330003181 | null | 33.4 | Curative (C) | 2016-03-22 | 2016-06-24 | NB HRNBL-1 COJEC Ind COURSE B | Y | N | 330001527 | NOT MATCHED |
| 330006400 | 330010193 | 1.77 | 59.9 | Curative (C) | 2017-03-14 | 2017-03-14 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330001533 | CISPLATIN + RT |
| 330006401 | 330003182 | null | 9.1 | Neo-adjuvant (N) | 2017-03-17 | 2017-03-17 | NB HRNBL-1 COJEC Ind COURSE C | N | N | 330001534 | NOT MATCHED |
| 330006402 | 330003182 | null | 23 | Palliative (P) | 2016-12-04 | 2016-12-04 | NB HRNBL-1 TVD | 02 | N | 330001534 | NOT MATCHED |
| 330006403 | 330010195 | 1.72 | 101.2 | Curative (C) | 2013-08-28 | 2013-09-26 | CISPLATIN + RT | N | N | 330001552 | CISPLATIN + RT |
| 330006405 | 330007701 | 1.81 | null | Radical (R) | 2013-11-21 | 2013-12-17 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 330001554 | CISPLATIN + RT |
| 330006406 | 330003187 | 1.63 | 92 | Curative (C) | 2014-08-31 | 2014-09-27 | Cisplatin + Radiotherapy | null | null | 330001555 | CISPLATIN + RT |
| 330006407 | 330007702 | null | 48.95 | Curative (C) | 2014-07-28 | 2014-08-12 | CISPLATIN + RT | 02 | Y | 330001563 | CISPLATIN + RT |
| 330006408 | 330010197 | 1.83 | 107.2 | Curative (C) | 2017-09-16 | 2017-09-25 | Cisplatin 100 + RT(H&N) 1 day | 2 | Y | 330001567 | CISPLATIN + RT |
| 330006409 | 330010197 | 1.86 | 83.1 | Adjuvant (A) | 2014-09-06 | 2014-09-07 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 330001567 | CISPLATIN + RT |